The expression of several lncRNAs has been shown to be regulated by TP53 [88], the deletions of which are associated with adverse outcome in patients with chronic lymphocytic leukemia (CLL) [89]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.